Nguy cơ cao về tỷ lệ tử vong không do ung thư ở bệnh nhân ung thư bàng quang: bằng chứng từ SEER-Medicaid

Abdel-Rahman O (2017) Risk of cardiac death among cancer survivors in the United States: a SEER database analysis. Expert Rev Anticancer Ther 17(9):873–878 Abou Dagher G, El Khuri C, Chehadeh AA et al (2017) Are patients with cancer with sepsis and bacteraemia at a higher risk of mortality? A retrospective chart review of patients presenting to a tertiary care centre in Lebanon. BMJ Open 7(3):e13502 Choi YH, Park Y, Hur KJ et al (2022) Duration of diabetes mellitus and risk of kidney and bladder cancer: a longitudinal nationwide cohort study. Am J Cancer Res 12(8):4050–4061 Dai ZH, Tang M, Chen YL et al (2022) Incidence and risk factors for cerebrovascular-specific mortality in patients with colorectal cancer: a registry-based cohort study involving 563,298 patients. Cancers (basel). 14(9):2053 Deckx L, van den Akker M, Metsemakers J et al (2012) Chronic diseases among older cancer survivors. J Cancer Epidemiol 2012:206414 Du B, Wang F, Wu L et al (2021) Cause-specific mortality after diagnosis of thyroid cancer: a large population-based study. Endocrine 72(1):179–189 Gill E, Sandhu G, Ward DG et al (2021) The sirenic links between diabetes, obesity, and bladder cancer. Int J Mol Sci 22(20):11150 Guan T, Qiu Z, Su M et al (2021) Cardiovascular death risk in primary central nervous system lymphoma patients treated with chemotherapy: a registry-based cohort study. Front Oncol 11:641955 Jalanko T, de Jong JJ, Gibb EA et al (2020) Genomic subtyping in bladder cancer. Curr Urol Rep 21(2):9 Klose K, Packeiser E, Müller P et al (2021) Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line. PLoS ONE 16(9):e257403 Kochanek KD, Murphy SL, Xu J et al (2019a) Deaths: final data for 2017. Natl Vital Stat Rep 68(9):1–77 Kochanek M, Schalk E, von Bergwelt-Baildon M et al (2019b) Management of sepsis in neutropenic cancer patients: 2018 guidelines from the infectious diseases working party (AGIHO) and intensive care working party (iCHOP) of the german society of hematology and medical oncology (DGHO). Ann Hematol 98(5):1051–1069 Lam BQ, Srivastava R, Morvant J et al (2021) Association of diabetes mellitus and alcohol abuse with cancer: molecular mechanisms and clinical significance. Cells-Basel 10(11):3077 Lenis AT, Lec PM, Chamie K et al (2020) Bladder cancer: a review. JAMA 324(19):1980–1991 Li J, Pang H, Sun Z et al (2020) Health status of middle-aged and older cancer survivors: a nationwide cross-sectional study from the China Health and Retirement Longitudinal Study (CHARLS). Ann Transl Med 8(5):183 Liu C, Sun J, Xu J et al (2022) Metformin use on incidence and oncologic outcomes of bladder cancer patients with T2DM: an updated meta-analysis. Front Pharmacol 13:865988 Liyanage UK, Moore TT, Joo HG et al (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169(5):2756–2761 Lu Y, Tao J (2021) Diabetes mellitus and obesity as risk factors for bladder cancer prognosis: a systematic review and meta-analysis. Front Endocrinol 12:699732 Marrie RA, Maxwell C, Mahar A et al (2021) Cancer incidence and mortality rates in multiple sclerosis: a matched cohort study. Neurology 96(4):e501–e512 Nishijima TF, Shachar SS, Nyrop KA et al (2017) Safety and tolerability of PD-1/PD-L1 inhibitors compared with chemotherapy in patients with advanced cancer: a meta-analysis. Oncologist 22(4):470–479 Oh CM, Lee D, Kong HJ et al (2020) Causes of death among cancer patients in the era of cancer survivorship in Korea: attention to the suicide and cardiovascular mortality. Cancer Med 9(5):1741–1752 Richters A, Aben K, Kiemeney L (2020) The global burden of urinary bladder cancer: an update. World J Urol 38(8):1895–1904 Robertson AG, Kim J, Al-Ahmadie H et al (2018) Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 174(4):1033 Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331(6024):1565–1570 Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34 Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30 Siegel RL, Miller KD, Fuchs HE et al (2021) Cancer statistics, 2021. CA Cancer J Clin 71(1):7–33 Simonaggio A, Michot JM, Voisin AL et al (2019) Evaluation of readministration of immune checkpoint inhibitors after immune-related adverse events in patients with cancer. JAMA Oncol 5(9):1310–1317 Song P, Lu N, Zhang J et al (2022) Cause of death of patients with non-muscular invasive, non-metastatic muscular invasive and metastatic bladder cancer after diagnosis. Am J Transl Res 14(5):3494–3515 Sturgeon KM, Deng L, Bluethmann SM et al (2019) A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J 40(48):3889–3897 Wang S, Ge C, Zhang J (2022a) Cardiovascular mortality risk in patients with bladder cancer: a population-based study. J Cardiovasc Dev Dis 9(8):255 Wang Z, Ong WYF, Shen T et al (2022b) Beyond diabetes mellitus: role of metformin in non-muscle-invasive bladder cancer. Singap Med J 63(4):209–213 Yang F, Li C, Guo Y et al (2021) Effects of radical cystectomy, radiotherapy, and chemotherapy on the risk of long-term heart-specific death in bladder cancer patients. Transl Androl Urol 10(10):3826–3836 Zhang Y, Pan X, Chen J et al (2020) Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies. Br J Cancer 122(7):1085–1093 Zhang H, Lin W, Chen D et al (2021) Cardiovascular and other competing causes of death in male breast cancer patients: a population-based epidemiologic study. Clin Interv Aging 16:1393–1401 Zhang J, Chang S, Chiang M et al (2021) Survival impact of current-smoking-related COPD or COPD with acute exacerbation. J Pers Med 11(10):958